The Cost Variability of Orthobiologics.


Journal

Sports health
ISSN: 1941-0921
Titre abrégé: Sports Health
Pays: United States
ID NLM: 101518422

Informations de publication

Date de publication:
Historique:
pubmed: 31 10 2019
medline: 14 1 2020
entrez: 31 10 2019
Statut: ppublish

Résumé

Mixed results exist regarding the benefit of orthobiologic injections. The purpose of this study was to assess the variability in costs for platelet-rich plasma (PRP) and stem cell (SC) injections and evaluate for variables that influence pricing. There will be significant variability in the cost of PRP and SC injections throughout the United States. Descriptive epidemiology study. Level 3. Calls were made to 1345 orthopaedic sports medicine practices across the United States inquiring into the availability of PRP or SC knee injections and associated costs. In addition to pricing, the practice type, number of providers, and population and income demographics were recorded. Univariate statistical analyses were used to identify differences in availability and cost between variables. Of the contacted offices that provided information on both PRP and SC availability (n = 1325), 268 (20.2%) offered both treatments, 550 (41.5%) offered only PRP injections, 20 (1.5%) offered only SC injections, and 487 (36.8%) did not offer either treatment. The mean ± SD cost of a PRP injection was $707 ± $388 (range, $175-$4973), and the mean cost of an SC injection was $2728 ± $1584 (range, $300-$12,000). Practices offering PRP and SC injections tended to be larger (PRP, 12.0 physicians per practice vs. 8.1 [ While the majority of sports medicine practices across the United States offer some type of orthobiologic injection, there exists significant variability in the cost of these injections. This study demonstrates the significant variability in costs of orthobiologic injections throughout the country, which will allow sports medicine physicians to appreciate the value of these injections when counseling patients on available treatment options.

Sections du résumé

BACKGROUND BACKGROUND
Mixed results exist regarding the benefit of orthobiologic injections. The purpose of this study was to assess the variability in costs for platelet-rich plasma (PRP) and stem cell (SC) injections and evaluate for variables that influence pricing.
HYPOTHESIS OBJECTIVE
There will be significant variability in the cost of PRP and SC injections throughout the United States.
STUDY DESIGN METHODS
Descriptive epidemiology study.
LEVEL OF EVIDENCE METHODS
Level 3.
METHODS METHODS
Calls were made to 1345 orthopaedic sports medicine practices across the United States inquiring into the availability of PRP or SC knee injections and associated costs. In addition to pricing, the practice type, number of providers, and population and income demographics were recorded. Univariate statistical analyses were used to identify differences in availability and cost between variables.
RESULTS RESULTS
Of the contacted offices that provided information on both PRP and SC availability (n = 1325), 268 (20.2%) offered both treatments, 550 (41.5%) offered only PRP injections, 20 (1.5%) offered only SC injections, and 487 (36.8%) did not offer either treatment. The mean ± SD cost of a PRP injection was $707 ± $388 (range, $175-$4973), and the mean cost of an SC injection was $2728 ± $1584 (range, $300-$12,000). Practices offering PRP and SC injections tended to be larger (PRP, 12.0 physicians per practice vs. 8.1 [
CONCLUSION CONCLUSIONS
While the majority of sports medicine practices across the United States offer some type of orthobiologic injection, there exists significant variability in the cost of these injections.
CLINICAL RELEVANCE CONCLUSIONS
This study demonstrates the significant variability in costs of orthobiologic injections throughout the country, which will allow sports medicine physicians to appreciate the value of these injections when counseling patients on available treatment options.

Identifiants

pubmed: 31665613
doi: 10.1177/1941738119880256
pmc: PMC6931181
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-98

Références

Arthroscopy. 2015 Feb;31(2):306-20
pubmed: 25450417
Pain Med. 2018 Dec 29;:null
pubmed: 30597057
Br J Sports Med. 2017 Aug;51(15):1125-1133
pubmed: 28258177
Arthroscopy. 2016 Mar;32(3):495-505
pubmed: 26432430
Aesthetic Plast Surg. 2018 Apr;42(2):603-609
pubmed: 29101441
J Bone Joint Surg Am. 2017 Oct 18;99(20):1769-1779
pubmed: 29040132
J Knee Surg. 2015 Feb;28(1):29-34
pubmed: 25268794
J Knee Surg. 2018 Jul;31(6):551-556
pubmed: 28738432
Orthop J Sports Med. 2016 Dec 21;4(12):2325967116676241
pubmed: 28210648
J Knee Surg. 2019 Sep;32(9):879-885
pubmed: 30189436
JAMA. 2018 Mar 13;319(10):1024-1039
pubmed: 29536101
Am J Orthop (Belle Mead NJ). 2016 Jul-Aug;45(5):290-326
pubmed: 27552452
Aesthet Surg J. 2015 Feb;35(2):218-24
pubmed: 25657294

Auteurs

Amit Mukesh Momaya (AM)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Andrew Sullivan McGee (AS)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Alexander R Dombrowsky (AR)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Alan Joshua Wild (AJ)

Alabama College of Osteopathic Medicine, Dothan, Alabama.

Naqeeb M Faroqui (NM)

Mercer University School of Medicine, Columbus, Georgia.

Raymond P Waldrop (RP)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Jun Kit He (JK)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Eugene W Brabston (EW)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Brent Andrew Ponce (BA)

Department of Orthopaedic Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH